Jack A Sava, MD | |
110 Irving St Nw, Rm 4b39, Washington, DC 20010-2976 | |
(202) 877-5190 | |
(202) 877-3173 |
Full Name | Jack A Sava |
---|---|
Gender | Male |
Speciality | General Surgery |
Experience | 30 Years |
Location | 110 Irving St Nw, Washington, District Of Columbia |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1689665960 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
2086S0102X | Surgery - Surgical Critical Care | MD33277 (District Of Columbia) | Primary |
Facility Name | Location | Facility Type |
---|---|---|
Medstar Washington Hospital Center | Washington, DC | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Whc Physician Group Llc | 6103093513 | 312 |
News Archive
Spinal muscular atrophy (SMA) is the leading genetic cause of death in children under 2, with no treatment other than supportive care. In the Proceedings of the National Academy of Sciences, researchers at Children's Hospital Boston show how loss or mutation of the SMA gene causes progressive muscle degeneration and weakness, and suggest a promising approach to treating the condition, sometimes referred to as a "Lou Gehrig's disease of babies."
A new study from Finland, published in February 2020 in the Journal of the American Heart Association, shows that many patients allow unhealthy habits to linger or creep in even after starting medications for high blood pressure or blood cholesterol.
The American Heart Association and Heart Rhythm Society today announced a collaboration designed to advance research and improve the delivery of care for people with an irregular heartbeat known as atrial fibrillation (AFib).
Pfizer Inc. announced today that based on discussions with the U.S. Food and Drug Administration (FDA), it will be discontinuing commercial availability of Mylotarg® (gemtuzumab ozogamicin for Injection) (used for the treatment of relapsed acute myeloid leukemia (AML)) in the United States and that it will be voluntarily withdrawing the new drug application (NDA) for Mylotarg effective October 15, 2010.
› Verified 2 days ago
Entity Name | Whc Physician Group Llc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1700154226 PECOS PAC ID: 6103093513 Enrollment ID: O20120125000252 |
News Archive
Spinal muscular atrophy (SMA) is the leading genetic cause of death in children under 2, with no treatment other than supportive care. In the Proceedings of the National Academy of Sciences, researchers at Children's Hospital Boston show how loss or mutation of the SMA gene causes progressive muscle degeneration and weakness, and suggest a promising approach to treating the condition, sometimes referred to as a "Lou Gehrig's disease of babies."
A new study from Finland, published in February 2020 in the Journal of the American Heart Association, shows that many patients allow unhealthy habits to linger or creep in even after starting medications for high blood pressure or blood cholesterol.
The American Heart Association and Heart Rhythm Society today announced a collaboration designed to advance research and improve the delivery of care for people with an irregular heartbeat known as atrial fibrillation (AFib).
Pfizer Inc. announced today that based on discussions with the U.S. Food and Drug Administration (FDA), it will be discontinuing commercial availability of Mylotarg® (gemtuzumab ozogamicin for Injection) (used for the treatment of relapsed acute myeloid leukemia (AML)) in the United States and that it will be voluntarily withdrawing the new drug application (NDA) for Mylotarg effective October 15, 2010.
› Verified 2 days ago
Mailing Address | Practice Location Address |
---|---|
Jack A Sava, MD 1201 Seven Locks Rd, Suite 200, Rockville, MD 20854-2931 Ph: (301) 652-5771 | Jack A Sava, MD 110 Irving St Nw, Rm 4b39, Washington, DC 20010-2976 Ph: (202) 877-5190 |
News Archive
Spinal muscular atrophy (SMA) is the leading genetic cause of death in children under 2, with no treatment other than supportive care. In the Proceedings of the National Academy of Sciences, researchers at Children's Hospital Boston show how loss or mutation of the SMA gene causes progressive muscle degeneration and weakness, and suggest a promising approach to treating the condition, sometimes referred to as a "Lou Gehrig's disease of babies."
A new study from Finland, published in February 2020 in the Journal of the American Heart Association, shows that many patients allow unhealthy habits to linger or creep in even after starting medications for high blood pressure or blood cholesterol.
The American Heart Association and Heart Rhythm Society today announced a collaboration designed to advance research and improve the delivery of care for people with an irregular heartbeat known as atrial fibrillation (AFib).
Pfizer Inc. announced today that based on discussions with the U.S. Food and Drug Administration (FDA), it will be discontinuing commercial availability of Mylotarg® (gemtuzumab ozogamicin for Injection) (used for the treatment of relapsed acute myeloid leukemia (AML)) in the United States and that it will be voluntarily withdrawing the new drug application (NDA) for Mylotarg effective October 15, 2010.
› Verified 2 days ago
Dr. Andrea Badillo, MD Surgery Medicare: Medicare Enrolled Practice Location: 111 Michigan Ave Nw, Washington, DC 20010 Phone: 202-476-2451 Fax: 202-476-4174 | |
Jerome Alain Byam, Surgery Medicare: Accepting Medicare Assignments Practice Location: 1310 Southern Ave Se, Washington, DC 20032 Phone: 202-574-6000 | |
Dr. Steven Macht, MD Surgery Medicare: Not Enrolled in Medicare Practice Location: 2021 K St Nw, #217, Washington, DC 20006 Phone: 202-887-8120 Fax: 202-887-8288 | |
Earl Hodin, MD Surgery Medicare: Not Enrolled in Medicare Practice Location: 111 Michigan Ave Nw, Washington, DC 20010 Phone: 202-884-2151 | |
Dr. Brandon W Propper, MD Surgery Medicare: Accepting Medicare Assignments Practice Location: 2150 Pennsylvania Ave Nw, Washington, DC 20037 Phone: 202-741-3210 | |
David H Song, MD Surgery Medicare: Accepting Medicare Assignments Practice Location: 3800 Reservoir Rd Nw, Phc Building, First Floor, Washington, DC 20007 Phone: 202-444-8751 Fax: 202-444-7204 | |
Melissa Martinez Anastacio, MD Surgery Medicare: Accepting Medicare Assignments Practice Location: 110 Irving St Nw, Room 4b42, Washington, DC 20010 Phone: 202-877-7259 Fax: 202-877-7258 |